GT
PMC

Glenmede Trust’s PharMerica Corporation PMC Stock Holding History

Glenmede Trust’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-137
Closed -$4K – 2902
2017
Q3 		$4K Hold
137
– – ﹤0.01% 2440
2017
Q2 		$3K Hold
137
– – ﹤0.01% 2451
2017
Q1 		$3K Buy
+137
New +$3.38K ﹤0.01% 2451
2016
Q2 		– Sell
-260
Closed -$5K – 2814
2016
Q1 		$5K Buy
260
+65
+33% +$1.73K ﹤0.01% 2237
2015
Q4 		$6K Buy
195
+43
+28% +$1.35K ﹤0.01% 2230
2015
Q3 		$3K Buy
152
+90
+145% +$3.02K ﹤0.01% 2452
2015
Q2 		$2K Buy
+62
New +$1.9K ﹤0.01% 2490

Glenmede Trust's PMC Position: Q4 2017 in Review

Glenmede Trust sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 137 shares — an estimated $4K sold.

Glenmede Trust first reported a position in PMC in Q2 2015 and held it in 7 quarters. The position peaked at $6K in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Glenmede Trust reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Glenmede Trust sold 137 PharMerica Corporation shares in Q4 2017, an estimated $4K.
  • Glenmede Trust first reported a position in PharMerica Corporation in Q2 2015 and held it in 7 quarters.
  • Glenmede Trust's PharMerica Corporation position peaked at $6K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Glenmede Trust's 13F filing for Q4 2017, filed 15 Feb 2018.